A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases
CR Isasi, RM Moadel, MD Blaufox - Breast cancer research and treatment, 2005 - Springer
Objective. To evaluate the diagnostic performance of 18 F-2-deoxy-2-fluoro-d-glucose-
positron emission tomography (FDG-PET) in the evaluation of breast cancer recurrence and …
positron emission tomography (FDG-PET) in the evaluation of breast cancer recurrence and …
[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective …
MG Hildebrandt, O Gerke, C Baun, K Falch… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To prospectively investigate the diagnostic accuracy of [18F] fluorodeoxyglucose
(FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point …
(FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point …
FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis
LL Pan, Y Han, XG Sun, JJ Liu, H Gang - Journal of cancer research and …, 2010 - Springer
Background and purpose Breast carcinoma is the most common cancer in female patients
with a propensity for recurrence and metastases. The accuracy of ultrasound (US) …
with a propensity for recurrence and metastases. The accuracy of ultrasound (US) …
Role of positron emission tomography for the monitoring of response to therapy in breast cancer
This review considers the potential utility of positron emission tomography (PET) tracers in
the setting of response monitoring in breast cancer, with a special emphasis on glucose …
the setting of response monitoring in breast cancer, with a special emphasis on glucose …
Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management
E Piperkova, B Raphael, ME Altinyay… - Clinical nuclear …, 2007 - journals.lww.com
Purpose: To evaluate the impact of F-18 fluorodeoxyglucose (FDG) positron emission
tomography with fused computerized tomography (PET/CT) in comparison with same day …
tomography with fused computerized tomography (PET/CT) in comparison with same day …
Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma
Purpose Although initial studies have shown the utility of fluorine-18 fluorodeoxyglucose (F-
18 FDG) PET in the detection and restaging of recurrent breast carcinoma, scarce literature …
18 FDG) PET in the detection and restaging of recurrent breast carcinoma, scarce literature …
Standardized uptake values from PET/MRI in metastatic breast cancer: An organ‐based comparison with PET/CT
AC Pujara, RA Raad, F Ponzo, C Wassong… - The breast …, 2016 - Wiley Online Library
Quantitative standardized uptake values (SUV s) from fluorine‐18 (18F) fluorodeoxyglucose
(FDG) positron emission tomography/computed tomography (PET/CT) are commonly used …
(FDG) positron emission tomography/computed tomography (PET/CT) are commonly used …
18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis
S Hong, J Li, S Wang - Surgical oncology, 2013 - Elsevier
BACKGROUND: We performed a meta-analysis to evaluate the value of 18FDG PET-CT for
diagnosis of distant metastases in breast cancer patients. METHODS: Studies about PET-CT …
diagnosis of distant metastases in breast cancer patients. METHODS: Studies about PET-CT …
Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer
LM Sawicki, J Grueneisen, BM Schaarschmidt… - European journal of …, 2016 - Elsevier
Objectives To compare the diagnostic performance of 18 F-fluordesoxyglucose positron
emission tomography/magnetic resonance imaging (18 F-FDG PET/MRI) with 18 F-FDG …
emission tomography/magnetic resonance imaging (18 F-FDG PET/MRI) with 18 F-FDG …
The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET
ME Schneider-Kolsky, S Hart, J Fox, P Midolo… - Breast Cancer …, 2010 - Springer
Introduction The aims of this study were to investigate whether drug sequence (docetaxel
followed by anthracyclines or the drugs in reverse order) affects changes in the maximal …
followed by anthracyclines or the drugs in reverse order) affects changes in the maximal …